Charles Ishak

Has grant

Assistant Professor

The University of Texas MD Anderson Cancer Center
Country flagUnited States
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Overcoming epigenetic therapy resistance to augment immunotherapy in ovarian cancer

Open Date: 2019-04-01

Close Date: 2021-04-01

Grant: Close

De-regulation of retroelements as an emerging therapeutic opportunity in ovarian cancer

Open Date: 2019-03-01

Close Date: 2019-03-01

Grant: Close

De-regulation of retroelements as an emerging therapeutic opportunity in ovarian cancer

Open Date: 2018-01-01

Close Date: 2018-01-01

Grant: Close

Contributions of repetitive elements to immune evasion in cancer

Open Date: 2017-07-01

Close Date: 2018-07-01

Articles (1)

Epigenetic therapies facilitate transcription of immunogenic repetitive elements that cull cancer cells through “viral mimicry” responses. Paradoxically, cancer-initiating events also facilitate transcription of repetitive elements. Contributions of repetitive element transcription toward cancer initiation, and the mechanisms by which cancer cells evade lethal viral mimicry responses during tumor initiation remain poorly understood. In this report, we characterize premalignant lesions of the fallopian tube along with syngeneic epithelial ovarian cancer models to explore the earliest events of tumorigenesis following the loss of the p53 tumor suppressor protein. We report that p53 loss permits the transcription of immunogenic repetitive elements and chronic viral mimicry activation that increases cellular tolerance of cytosolic nucleic acids and diminishes cellular immunogenicity. This selection process can be partially attenuated pharmacologically. Altogether, these results reveal that viral mimicry conditioning following p53 loss promotes immune evasion and may represent a pharmacologic target for early cancer interception. Significance: Our landmark discovery of viral mimicry characterized repetitive elements as immunogenic stimuli that cull cancer cells. If expressed repetitive elements cull cancer cells, why does every human cancer express repetitive elements? Our report offers an exciting advancement toward understanding this paradox and how to exploit this mechanism for cancer interception. See related commentary by Murayama and Cañadas, p. 670

Year:

2025

Collaborators (9)

Ming Sound Tsao

Director (Princess Margaret Cancer Centre Living Biobank Core Facility)

University Health Network

CANADA
View details

Anjelica Hodgson

University Health Network

CANADA
View details

Tiago Medina

Tenured Associate Professor

University of Southern Denmark

DENMARK
View details

Shu Yi Shen

University Health Network

CANADA
View details

Trevor Shepherd

Professor

Western University

CANADA
View details

Amit M. Oza

University Health Network

CANADA
View details

Daniel De Carvalho

Associate Professor

University of Toronto

CANADA
View details

Katherine B. Chiappinelli

George Washington University

UNITED STATES
View details

Stephanie Gomez

Staff Scientist I

Children's National Health System

UNITED STATES
View details